Lisiena Hysenaj: Excited to Announce the Jeroen Roose Lab’s Latest Publication from Laila Karra Khalil
Lisiena Hysenaj, Translation Immunology Lead at Parvus Therapeutics Inc, shared on LinkedIn:
”Excited to announce the Jeroen Roose Lab’s latest publication from Laila Karra Khalil in Blood Journals Portfolio!
In this study, the team utilized single-cell proteomics to explore how changes in the Ras pathway influence hematopoiesis, highlighting variations in lineage bias, stem/progenitor cell maintenance, and cellular metabolism.
This project was a truly collaborative effort, involving diverse teams (Matt Spitzer, Alexis Combes) at University of California, San Francisco and significant contributions from Rafael J. Argüello at CIML in France.
I am grateful for the chance to work with such talented colleagues and to strengthen our partnerships with collaborators in France.”
Read the full article in Blood Advances.
Article: Single-cell proteomics characterization of bone marrow hematopoiesis with distinct Ras pathway lesions
Authors: Laila Karra, Anna-Marie Finger, Lauren Shechtman, Milana Krush, Rita Meng-Yao Huang, Morgan Prinz, Iliana Tennvooren, Kriti Bahl, Lisiena Hysenaj, Paulina G. Gonzalez, Alexis J. Combes, Hugo Gonzalez, Rafael J. Argüello, Matthew H. Spitzer, Jeroen P. Roose
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH